Announcements

Immunome, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 9, 2026, reporting a net loss of $212.749 million for the nine months ended September 30, 2026.

Insight Digital Partners II filed a Form 10-Q with the SEC on November 9, 2026, reporting financial results for the quarter and nine months ended September 30, 2026.

Ceva, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 9, 2026, reporting financial results for the three and nine months ended on that date.

ZipRecruiter, Inc. filed a quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission covering the fiscal quarter ended September 30, 2026, disclosing share counts as of November 2, 2026, and providing financial statements, management discussion, and an updated risk factor section.

Zentalis Pharmaceuticals, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 9, 2026, disclosing financial results, operational updates, and risk factors for the quarter.

Kemper Corporation filed a Form 8-K on November 9, 2026, announcing the release of its financial results for the third quarter of 2026 along with the availability of an investor supplement and earnings call presentation on its website.

ADC Therapeutics SA (NYSE:ADCT) filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 9, 2026, covering the company's financial condition and operations through the third quarter.